Literature DB >> 7833229

Stereoselective disposition of ibuprofen enantiomers in infants.

E Rey1, A Pariente-Khayat, L Gouyet, F Vauzelle-Kervroëdan, G Pons, P D'Athis, M C Dubois, I Murat, C Lassale, M Goehrs.   

Abstract

The pharmacokinetics of the enantiomers of ibuprofen were investigated after oral administration of a single 7.6 +/- 0.3 mg kg-1 dose of the racemate in 11 infants. Mean (+/- s.d.) half-lives were 1.6 +/- 0.5 h for S(+) and 1.5 +/- 0.5 h for R(-) and mean (+/- s.d.) AUC values were 31.5 +/- 14.3 mg l-1 h for S(+) and 36.6 +/- 13.8 mg l-1 h for R(-). Since plasma concentrations of the active S(+)-isomer were lower than those reported in adults, a higher dosage might be required in infants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833229      PMCID: PMC1364783          DOI: 10.1111/j.1365-2125.1994.tb04369.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Isomeric inversion of ibuprofen (R)-enantiomer in humans.

Authors:  D G Kaiser; G J Vangiessen; R J Reischer; W J Wechter
Journal:  J Pharm Sci       Date:  1976-02       Impact factor: 3.534

2.  High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urine.

Authors:  M P Knadler; S D Hall
Journal:  J Chromatogr       Date:  1989-09-29

3.  Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase.

Authors:  Z N Gaut; H Baruth; L O Randall; C Ashley; J R Paulsrud
Journal:  Prostaglandins       Date:  1975-07

4.  Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine.

Authors:  H R Ochs; D J Greenblatt; R Matlis; J Weinbrenner
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

5.  The correlation between blood levels of ibuprofen and clinical analgesic response.

Authors:  E M Laska; A Sunshine; I Marrero; N Olson; C Siegel; N McCormick
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

6.  Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates.

Authors:  F Jamali; N N Singh; F M Pasutto; A S Russell; R T Coutts
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

7.  Stereoselective disposition of ibuprofen enantiomers in man.

Authors:  E J Lee; K Williams; R Day; G Graham; D Champion
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

8.  Ibuprofen levels in serum and synovial fluid.

Authors:  A L Mäkelä; M Lempiäinen; H Ylijoki
Journal:  Scand J Rheumatol Suppl       Date:  1981

9.  Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children.

Authors:  M T Kelley; P D Walson; J H Edge; S Cox; M E Mortensen
Journal:  Clin Pharmacol Ther       Date:  1992-08       Impact factor: 6.875

10.  Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis.

Authors:  G Geisslinger; O Schuster; K P Stock; D Loew; G L Bach; K Brune
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more
  7 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery.

Authors:  F Jamali; C M Kunz-Dober
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 5.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

Review 6.  Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months.

Authors:  Victoria C Ziesenitz; Andreas Zutter; Thomas O Erb; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

7.  Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.

Authors:  Aline G J Engbers; Robert B Flint; Swantje Völler; Johan C A de Klerk; Irwin K M Reiss; Peter Andriessen; Kian D Liem; Pieter L J Degraeuwe; Siska Croubels; Joske Millecam; Karel Allegaert; Sinno H P Simons; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.